Health & Medicine · Cardiology · Cardiovascular Risk
ASCVD Risk Calculator
Estimates 10-year atherosclerotic cardiovascular disease (ASCVD) risk using the ACC/AHA Pooled Cohort Equations.
Calculator
Formula
The Pooled Cohort Equations calculate the linear combination of risk factors: ln(age), ln(total cholesterol), ln(HDL cholesterol), ln(treated or untreated systolic BP), diabetes status, and smoking status. Sex- and race-specific coefficient sets (\beta_i) are applied, along with baseline survivor functions (S_0) and mean coefficient values. The result is a probability of a first ASCVD event — nonfatal myocardial infarction, coronary heart disease death, or fatal/nonfatal stroke — over 10 years.
Source: Goff DC Jr. et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. Circulation. 2014;129(25 Suppl 2):S49-73.
How it works
The Pooled Cohort Equations were developed by pooling data from several large, prospective, community-based cohorts including the Atherosclerosis Risk in Communities (ARIC) study, the Cardiovascular Health Study (CHS), and the Coronary Artery Risk Development in Young Adults (CARDIA) study, among others. Separate sex- and race-specific equations were derived for White males, White females, African American males, and African American females. For individuals of other racial/ethnic backgrounds, the White equations are used as the best available approximation, though this is a recognized limitation.
The model uses a Cox proportional hazards framework to combine the natural logarithms of age, total cholesterol, HDL cholesterol, and systolic blood pressure — along with indicator variables for blood pressure treatment, diabetes, and current smoking — into a linear predictor. This predictor is exponentiated and applied to a race- and sex-specific baseline survival function (S₀) to yield the probability of a first ASCVD event over 10 years: Risk = 1 − S₀^exp(ΣβᵢXᵢ − MeanCoeff). Each coefficient set was estimated from the pooled cohort data and reflects the relative contribution of each risk factor within its demographic group.
Clinically, the resulting 10-year risk percentage is used to classify patients into four risk tiers: low risk (<5%), borderline risk (5% to <7.5%), intermediate risk (7.5% to <20%), and high risk (≥20%). These categories directly inform ACC/AHA statin prescribing guidelines. Patients in the borderline or intermediate range may benefit from additional risk-enhancing factors or coronary artery calcium (CAC) scoring to refine the decision to initiate statin therapy. High-risk patients are typically candidates for moderate-to-high intensity statin therapy without further testing.
Worked example
Consider a 55-year-old White male with a total cholesterol of 213 mg/dL, HDL of 50 mg/dL, systolic blood pressure of 120 mmHg (untreated), who is not diabetic and does not smoke.
Using the White male equation, we compute the natural logarithms: ln(55) ≈ 4.007, ln(213) ≈ 5.361, ln(50) ≈ 3.912, ln(120) ≈ 4.787.
The linear predictor sum is calculated as: 12.344 × 4.007 + 11.853 × 5.361 + (−2.664) × 4.007 × 5.361 + (−7.990) × 3.912 + 1.769 × 4.007 × 3.912 + 1.764 × 4.787 + 0 (no diabetes) + 0 (non-smoker).
This gives approximately: 49.46 + 63.54 − 57.22 − 31.27 + 27.73 + 8.44 = 60.68.
Applying the formula: Risk = 1 − 0.9144^exp(60.68 − 61.18) = 1 − 0.9144^exp(−0.50) = 1 − 0.9144^0.607 ≈ 1 − 0.9487 ≈ 5.1%.
This places the patient in the borderline risk category (5% to <7.5%), where a clinician-patient discussion about the potential benefits of statin therapy and lifestyle modification is recommended.
Limitations & notes
The Pooled Cohort Equations have several important limitations. The model was derived primarily from White and African American populations; its accuracy in Hispanic, Asian, South Asian, and other ethnic groups is less well established, and the White equations used as surrogates may systematically over- or underestimate risk in these groups. The equations are validated for adults aged 40–79 years only; they should not be applied to younger or older individuals. Studies have suggested that the equations may overestimate risk by 75–150% in contemporary, well-treated populations, possibly because the cohorts were assembled in earlier decades when cardiovascular risk factor management was less aggressive. The calculator does not incorporate emerging risk-enhancing factors such as family history of premature ASCVD, chronic kidney disease, inflammatory conditions (e.g., rheumatoid arthritis, HIV), or coronary artery calcium score — all of which the 2018 ACC/AHA guidelines recommend considering in borderline-risk patients. Additionally, this tool is intended for primary prevention only; it is not appropriate for individuals who already have established ASCVD, as those patients are managed under different guidelines.
Frequently asked questions
What is ASCVD and what events does this calculator predict?
ASCVD stands for atherosclerotic cardiovascular disease. This calculator predicts the 10-year risk of a first major ASCVD event, specifically nonfatal myocardial infarction (heart attack), coronary heart disease death, and fatal or nonfatal stroke. It does not predict heart failure, peripheral artery disease, or other cardiovascular conditions.
What 10-year risk percentage warrants statin therapy?
According to the 2018 ACC/AHA guidelines, patients with a 10-year ASCVD risk of 7.5% or higher are generally candidates for statin therapy discussion. Those with risk ≥20% are considered high-risk and typically benefit from high-intensity statins. For borderline-risk patients (5–7.5%), additional risk-enhancing factors or coronary artery calcium scoring may help guide the decision.
Is this calculator appropriate for all racial and ethnic groups?
The Pooled Cohort Equations have validated coefficient sets only for White and African American individuals. For patients of Hispanic, Asian, or other ethnic backgrounds, the White equations are used as a proxy, but accuracy may be reduced. Clinicians should consider this limitation and potentially use supplementary risk assessment tools or clinical judgment for these populations.
Can this calculator be used for patients who already have heart disease?
No. The ASCVD Risk Calculator is designed exclusively for primary prevention — estimating the risk of a first cardiovascular event in patients without established ASCVD. Patients who already have had a heart attack, stroke, or have known coronary artery disease are classified as very high risk and are managed under separate secondary prevention guidelines.
How does blood pressure treatment status affect the calculation?
The Pooled Cohort Equations use different coefficients for treated versus untreated systolic blood pressure. This is because the same blood pressure value carries a different risk implication depending on whether it is controlled with medication. A systolic BP of 130 mmHg that is already being treated with antihypertensives implies a higher underlying cardiovascular risk than the same BP in an untreated individual.
Last updated: 2025-01-15 · Formula verified against primary sources.